ArticleGeroScience2026
Is morbidity compressing or expanding? Cross-national trends in midlife multimorbidity across cohorts.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While life expectancy has increased globally, it remains uncertain whether recent generations are entering midlife with a greater or lower burden of chronic disease and whether these cohort patterns differ by gender. Moreover, cross-national evidence comparing cohort differences in morbidity remains limited, constraining our understanding of how health trajectories vary across national contexts. Using harmonized longitudinal data from the Health and Retirement Study and 3 international partner studies (13 countries in total), we compared two midlife birth cohorts-adults aged 50-58 surveyed in 2006 and 2014-each followed for 4 years. Multimorbidity was measured as the count of eight self-reported chronic conditions. Over half of the study countries experienced increases in multimorbidity between 2006 and 2014, including the USA (0.22; 95% CI = [0.12, 0.32]), the UK (0.09; 95% CI = [0.00, 0.17]), and Switzerland (0.36; 95% CI = [0.22, 0.49]), consistent with an expansion of morbidity. In contrast, South Korea showed a decline (-0.12; 95% CI = [-0.17, -0.07]), suggesting potential evidence of morbidity compression. Gender-stratified analyses showed heterogeneity, with larger increases among women in the USA and a decline concentrated among women in South Korea. These findings underscore the importance of national context in shaping cohort health trajectories and suggest that policy environments may play a critical role in mitigating morbidity expansion.
Indexed as
Identifiers
42113324What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.